- Type / Class
- Equity / Common Stock
- Shares outstanding
- 44,038,904
- Total 13F shares
- 44,848,348
- Share change
- +3,574,465
- Total reported value
- $652,883,600
- Price per share
- $14.56
- Number of holders
- 114
- Value change
- +$53,846,940
- Number of buys
- 63
- Number of sells
- 40
Quarterly Holders Quick Answers
What is CUSIP 08659B102?
CUSIP 08659B102 identifies BBNX - Beta Bionics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 08659B102:
Top shareholders of BBNX - Beta Bionics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
13D/G
|
Company |
11%
from 13D/G
|
4,928,019
|
$60,306,825 | — | 31 Mar 2025 | |
| Sands Capital Life Sciences Pulse Fund II, L.P. |
13D/G
|
— |
8.2%
|
3,570,113
|
$48,410,732 | +$5,636,946 | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
8.9%
|
3,901,599
|
$47,346,454 | — | 31 Mar 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
7.7%
|
3,395,341
|
$41,558,974 | — | 31 Mar 2025 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
7.6%
|
3,332,220
|
$40,786,373 | — | 31 Mar 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
7.5%
|
3,299,870
|
$40,390,409 | — | 31 Mar 2025 | |
| Sands Capital Alternatives, LLC |
13F
|
Company |
7%
|
3,103,782
|
$37,990,292 | — | 31 Mar 2025 | |
| Omega Fund Management, LLC |
13F
|
Company |
4.5%
|
1,988,287
|
$24,336,633 | — | 31 Mar 2025 | |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
|
Company |
3.7%
|
1,593,608
|
$21,609,324 | $0 | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
3.2%
|
1,427,150
|
$17,468,317 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
3.2%
|
1,401,653
|
$17,156,233 | — | 31 Mar 2025 | |
| Holocene Advisors, LP |
13F
|
Company |
2.5%
|
1,107,812
|
$13,559,619 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
2.5%
|
1,097,263
|
$13,430,499 | — | 31 Mar 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.3%
|
1,016,000
|
$12,435,840 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.1%
|
946,350
|
$11,583,324 | — | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
2%
|
882,277
|
$10,799,070 | — | 31 Mar 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
2.1%
|
932,128
|
$9,710,291 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.6%
|
709,255
|
$8,681,282 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.5%
|
673,658
|
$8,245,572 | — | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.5%
|
665,653
|
$7,794,797 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.4%
|
636,204
|
$7,788,000 | — | 31 Mar 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.1%
|
500,000
|
$6,120,000 | — | 31 Mar 2025 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.97%
|
429,120
|
$5,252,429 | — | 31 Mar 2025 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.84%
|
369,225
|
$4,519,314 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.83%
|
364,329
|
$4,459,393 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.69%
|
306,017
|
$3,746,513 | — | 31 Mar 2025 | |
| Longaeva Partners L.P. |
13F
|
Company |
0.63%
|
275,825
|
$3,376,098 | — | 31 Mar 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.52%
|
228,160
|
$2,793,000 | — | 31 Mar 2025 | |
| Jain Global LLC |
13F
|
Company |
0.34%
|
148,512
|
$1,817,787 | — | 31 Mar 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.34%
|
148,105
|
$1,812,805 | — | 31 Mar 2025 | |
| BRAIDWELL LP |
13F
|
Company |
0.32%
|
140,000
|
$1,713,600 | — | 31 Mar 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.31%
|
137,322
|
$1,680,820 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.28%
|
125,000
|
$1,530,000 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.28%
|
124,340
|
$1,521,922 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.25%
|
111,487
|
$1,364,601 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.24%
|
105,972
|
$1,297,097 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.23%
|
101,614
|
$1,243,755 | — | 31 Mar 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.17%
|
75,000
|
$918,000 | — | 31 Mar 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.15%
|
67,611
|
$827,559 | — | 31 Mar 2025 | |
| Bellevue Group AG |
13F
|
Company |
0.15%
|
66,825
|
$817,938 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.14%
|
61,558
|
$753,470 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.13%
|
58,422
|
$715,085 | — | 31 Mar 2025 | |
| Point72 (DIFC) Ltd |
13F
|
Company |
0.13%
|
57,158
|
$699,608 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.12%
|
54,025
|
$661,267 | — | 31 Mar 2025 | |
| Ghisallo Capital Management LLC |
13F
|
Company |
0.11%
|
50,000
|
$612,000 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.11%
|
49,878
|
$610,507 | — | 31 Mar 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.09%
|
39,876
|
$488,082 | — | 31 Mar 2025 | |
| Evanson Asset Management, LLC |
13F
|
Company |
0.09%
|
38,772
|
$474,569 | — | 31 Mar 2025 | |
| Values First Advisors, Inc. |
13F
|
Company |
0.09%
|
37,585
|
$457,446 | — | 31 Mar 2025 | |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP |
13F
|
Company |
0.07%
|
31,000
|
$379,440 | — | 31 Mar 2025 |
Institutional Holders of Beta Bionics, Inc. - Common Stock (BBNX) as of Q2 2025
As of 30 Jun 2025,
Beta Bionics, Inc. - Common Stock (BBNX) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,848,348 shares.
The largest 10 holders included
EVENTIDE ASSET MANAGEMENT, LLC, FARALLON CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, Soleus Capital Management, L.P., Sands Capital Alternatives, LLC, RTW INVESTMENTS, LP, MORGAN STANLEY, Omega Fund Management, LLC, PERCEPTIVE ADVISORS LLC, and DEERFIELD MANAGEMENT COMPANY, L.P..
This page lists
114
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
102
Q2 2025 holders
114
Holder diff
12
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.